Table 2.
Incidence rates and costs of inadvertent outpatient continuation of PPI-based SUP
| Year | ICU stay, n (%) | No ICU stay, n (%) | Total inappropriate use, n (%) | Total cost, US$ | Patient cost, US$ |
|---|---|---|---|---|---|
| 2010 | 68/141 (48.2%) | 676/1,745 (38.7%) | 744/1,886 (39.4%) | $6,610 | $1,983 |
| 2011 | 63/135 (46.7%) | 728/1,593 (45.7%) | 791/1,728 (45.8%) | $7,029 | $2,109 |
| 2012 | 57/106 (53.8%) | 805/1,451 (55.5%) | 862/1,557 (55.4%) | $7,422 | $2,226 |
| 2013 | 171/240 (71.3%) | 1,842/2,968 (62.1%) | 2,013/3,208 (62.7%) | $19,115 | $5,734 |
| Total | 359/622 (57.7%) | 4,051/7,757 (52.2%) | 4,410/8,379 (52.6%) | $40,175 | $12,053 |
Abbreviations: PPI, proton pump inhibitor; SUP, stress ulcer prophylaxis; ICU, intensive care unit.